Angiosarcoma;Angiosarkom

Hautarzt

Volumn 59, Issue 3, 2008, Pages 237-251

  Vogt, T ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Angiosarcoma; Atypical vascular lesion; Endothelium; Secondary angiosarcoma; Soft tissue sarcomas

Indexed keywords

ANGIOSARCOMA; BREAST CANCER; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; METASTASIS; PROGNOSIS; REVIEW; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION;

GERMANY; HEMANGIOSARCOMA; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 40549095380     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1486-2     Document Type: Review

References (27)

1. Abraham JA, Hornicek FJ, Kaufman AM et al. (2007) Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 14: 1953-1967
2. Bader AG, Kang S, Vogt PK (2006) Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103: 1475-1479
3. Bong AB, Bonnekoh B, Schon MP, Gollnick H (2005) Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa. J Am Acad Dermatol 52: 20-23
4. Domfeh AB, Fichera M, Hunt JL (2006) Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck. Arch Pathol Lab Med 130: 1184-1187
5. Fata F, O'Reilly E, Ilson D et al. (1999) Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 86: 2034-2037
6. Fosmire SP, Dickerson EB, Scott AM et al. (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest 84: 562-572
7. Fury MG, Antonescu CR, Van Zee KJ et al. (2005) A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11: 241-247
8. Gengler C, Coindre JM, Leroux A et al. (2007) Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group. Cancer 109: 1584-1598
9. Hafner C, Reichle A, Vogt T (2005) New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARg-agonists, Cox-2 inhibitors, mTOR Antagonists and metronomic chemotherapy. Current Cancer Drug Targets 5: 393-419
10. Higgins JP, Montgomery K, Wang L et al. (2003) Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays. Am J Surg Pathol 27: 58-64
11. Itakura E, Yamamoto H, Oda Y, Tsuneyoshi M (2008) Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 97: 74-81
12. Koontz BF, Miles EF, Rubio MA et al. (2007) Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies. Head Neck (in press)
13. Kopp HG, Kanz L, Hartmann JT (2006) Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide. Anticancer Drugs 17: 997-998
14. Mark RJ, Poen JC, Tran LM et al. (1996) Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77: 2400-2406
15. Mattoch IW, Robbins JB, Kempson RL, Kohler S (2007) Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases. J Am Acad Dermatol 57: 126-133
16. Mendenhall WM, Mendenhall CM, Werning JW et al. (2006) Cutaneous angiosarcoma. Am J Clin Oncol 29: 524-528
17. Nagano T, Tai Y, Higashida Y et al. (2007) Docetaxel monotherapy for angiosarcoma in an elderly patient. Arch Dermatol 143: 1602-1603
18. Sher T, Hennessy BT, Valero V et al. (2007) Primary angiosarcomas of the breast. Cancer 110: 173-178
19. Skubitz KM, Haddad PA (2005) Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 104: 361-366
20. Syed SP, Martin AM, Haupt HM et al. (2007) Angiostatin receptor annexin II in vascular tumors including angiosarcoma. Hum Pathol 38: 508-513
21. Thewes M, Elsner E, Wessner D et al. (2000) The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study. Int J Dermatol 39: 188-191
22. Thong PS, Ong KW, Goh NS et al. (2007) Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol 8: 950-952
23. Vogt T, Hafner C, Bross K et al. (2003) Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer 98: 2251-2256
24. West JG, Qureshi A, West JE et al. (2005) Risk of angiosarcoma following breast conservation: a clinical alert. Breast J 11: 115-123
25. Xu H, Edwards JR, Espinosa O et al. (2004) Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol 35: 857-861
26. Zindy F, Nilsson LM, Nguyen L et al. (2003) Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res 63: 5420-5427
27. Greene FL (2002) AJCC cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York Tokyo, pp 1933-1200